+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Radiopharmaceuticals Market Research Report by Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Procedural Volume, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 257 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4829949
UP TO OFF until Dec 31st 2022
The Global Radiopharmaceuticals Market size was estimated at USD 4,569.80 million in 2021, USD 4,851.52 million in 2022, and is projected to grow at a CAGR 6.34% to reach USD 6,610.33 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Radiopharmaceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine. The Diagnostic Nuclear Medicine is further studied across Pet Radiopharmaceuticals and Spect Radiopharmaceuticals. The Pet Radiopharmaceuticals is further studied across F-18 and Ru-82. The Spect Radiopharmaceuticals is further studied across Ga-67, I-123, Tc-99m, and Tl-201. The Therapeutic Nuclear Medicine is further studied across Alpha Emitters, Beta Emitters, and Brachytherapy Isotopes. The Beta Emitters is further studied across I-131, Lu-177, Re-186, Sm-153, and Y-90. The Brachytherapy Isotopes is further studied across Cs-131, I-125, Ir-192, and Pd-103.
  • Based on Procedural Volume, the market was studied across Diagnostic Procedures and Therapeutic Procedures. The Diagnostic Procedures is further studied across Pet Radiopharmaceutical Procedure and Spect Radiopharmaceuticals Procedure. The Therapeutic Procedures is further studied across Alpha Emitter Procedure, Beta Emitters Procedure, and Brachytherapy Isotopes Procedure.
  • Based on Application, the market was studied across Diagnostic Applications and Therapeutic Applications. The Diagnostic Applications is further studied across Pet Applications and Spect Applications. The Pet Applications is further studied across Cardiology Indication, Neurology Indication, and Oncology Indication. The Spect Applications is further studied across Cardiology, Lymphoma, Neurology, and Thyroid. The Therapeutic Applications is further studied across Bone Metastasis, Endocrine Tumors, Lymphoma Therapeutic, and Thyroid Therapeutic.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Radiopharmaceuticals market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Radiopharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Radiopharmaceuticals Market, including Alliance Holdings Medical Limited, Bayer AG, Beijing International Pharmaceutical Technology Co., Ltd., Bracco Group, Cardinal Health, Inc., Clarity Pharmaceuticals, Curium Pharma, Eckert & Ziegler Group, Eczacibasi-Monrol Nuclear Products Co., Fusion Pharmaceuticals Inc., GE Healthcare, Global Medical Solutions, LTD., Institute of Isotopes Co., LTD., IsoTherapeutics Group, LLC, Isotopia Molecular Imaging Ltd., Jubilant Pharma Holdings Inc., Lantheus Medical Imaging, Inc., Mallinckrodt PLC, Navidea Biopharmaceuticals, Inc., Northstar Medical Technologies LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings LLC, SHINE Medical Technologies, Siemens Healthineers AG, Sotera Health Holdings, LLC, and State Atomic Energy Corporation Rosatom.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Radiopharmaceuticals Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Radiopharmaceuticals Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Radiopharmaceuticals Market?
4. What is the competitive strategic window for opportunities in the Global Radiopharmaceuticals Market?
5. What are the technology trends and regulatory frameworks in the Global Radiopharmaceuticals Market?
6. What is the market share of the leading vendors in the Global Radiopharmaceuticals Market?
7. What modes and strategic moves are considered suitable for entering the Global Radiopharmaceuticals Market?
Frequently Asked Questions about the Global Radiopharmaceuticals Market

What is the estimated value of the Global Radiopharmaceuticals Market?

The Global Radiopharmaceuticals Market was estimated to be valued at $4569.8 Million in 2021.

What is the growth rate of the Global Radiopharmaceuticals Market?

The growth rate of the Global Radiopharmaceuticals Market is 6.3%, with an estimated value of $6610.33 Million by 2027.

What is the forecasted size of the Global Radiopharmaceuticals Market?

The Global Radiopharmaceuticals Market is estimated to be worth $6610.33 Million by 2027.

Who are the key companies in the Global Radiopharmaceuticals Market?

Key companies in the Global Radiopharmaceuticals Market include Alliance Holdings Medical Limited, Bayer AG, Beijing International Pharmaceutical Technology Co., Ltd., Bracco Group, Cardinal Health, Inc., Clarity Pharmaceuticals, Curium Pharma, Eckert & Ziegler Group and Monrol Nuclear Products Co..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Incidence and Prevalence of Target Conditions
5.1.1.2. Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
5.1.1.3. Initiatives to Reduce the Demand-Supply Gap of Mo-99
5.1.2. Restraints
5.1.2.1. Shorter Life of Radiopharmaceuticals
5.1.3. Opportunities
5.1.3.1. Adoption of Radiopharmaceuticals in Neurological Applications
5.1.3.2. Rising Number of Diagnostic Centers Especially in Developing Countries
5.1.4. Challenges
5.1.4.1. High Equipment Prices and Limited Hospital Budget
5.2. Cumulative Impact of COVID-19
6. Radiopharmaceuticals Market, by Type
6.1. Introduction
6.2. Diagnostic Nuclear Medicine
6.2.1. Pet Radiopharmaceuticals
6.2.1.1. F-18
6.2.1.2. Ru-82
6.2.2. Spect Radiopharmaceuticals
6.2.2.1. Ga-67
6.2.2.2. I-123
6.2.2.3. Tc-99M
6.2.2.4. Tl-201
6.3. Therapeutic Nuclear Medicine
6.3.1. Alpha Emitters
6.3.2. Beta Emitters
6.3.2.1. I-131
6.3.2.2. Lu-177
6.3.2.3. Re-186
6.3.2.4. Sm-153
6.3.2.5. Y-90
6.3.3. Brachytherapy Isotopes
6.3.3.1. Cs-131
6.3.3.2. I-125
6.3.3.3. Ir-192
6.3.3.4. Pd-103
7. Radiopharmaceuticals Market, by Procedural Volume
7.1. Introduction
7.2. Diagnostic Procedures
7.2.1. Pet Radiopharmaceutical Procedure
7.2.2. Spect Radiopharmaceuticals Procedure
7.3. Therapeutic Procedures
7.3.1. Alpha Emitter Procedure
7.3.2. Beta Emitters Procedure
7.3.3. Brachytherapy Isotopes Procedure
8. Radiopharmaceuticals Market, by Application
8.1. Introduction
8.2. Diagnostic Applications
8.2.1. Pet Applications
8.2.1.1. Cardiology Indication
8.2.1.2. Neurology Indication
8.2.1.3. Oncology Indication
8.2.2. Spect Applications
8.2.2.1. Cardiology
8.2.2.2. Lymphoma
8.2.2.3. Neurology
8.2.2.4. Thyroid
8.3. Therapeutic Applications
8.3.1. Bone Metastasis
8.3.2. Endocrine Tumors
8.3.3. Lymphoma Therapeutic
8.3.4. Thyroid Therapeutic
9. Americas Radiopharmaceuticals Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Radiopharmaceuticals Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Radiopharmaceuticals Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. Fpnv Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Alliance Holdings Medical Limited
13.2. Bayer Ag
13.3. Beijing International Pharmaceutical Technology Co., Ltd.
13.4. Bracco Group
13.5. Cardinal Health, Inc.
13.6. Clarity Pharmaceuticals
13.7. Curium Pharma
13.8. Eckert & Ziegler Group
13.9. Eczacibasi-Monrol Nuclear Products Co.
13.10. Fusion Pharmaceuticals Inc.
13.11. GE Healthcare
13.12. Global Medical Solutions, Ltd.
13.13. Institute of Isotopes Co., Ltd.
13.14. Isotherapeutics Group, LLC
13.15. Isotopia Molecular Imaging Ltd.
13.16. Jubilant Pharma Holdings Inc.
13.17. Lantheus Medical Imaging, Inc.
13.18. Mallinckrodt plc
13.19. Navidea Biopharmaceuticals, Inc.
13.20. Northstar Medical Technologies LLC
13.21. Novartis Ag
13.22. Ntp Radioisotopes Soc Ltd.
13.23. Pharmalogic Holdings LLC
13.24. Shine Medical Technologies
13.25. Siemens Healthineers Ag
13.26. Sotera Health Holdings, LLC
13.27. State Atomic Energy Corporation Rosatom
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL RADIOPHARMACEUTICALS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL RADIOPHARMACEUTICALS MARKET DYNAMICS
FIGURE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2027
FIGURE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, 2019-2027 (USD MILLION)
FIGURE 40. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, 2019-2027 (USD MILLION)
FIGURE 42. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, 2019-2027 (USD MILLION)
FIGURE 44. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 45. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2019-2027 (USD MILLION)
FIGURE 46. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 47. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, 2019-2027 (USD MILLION)
FIGURE 48. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 49. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, 2019-2027 (USD MILLION)
FIGURE 50. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 51. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, 2019-2027 (USD MILLION)
FIGURE 52. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 53. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, 2019-2027 (USD MILLION)
FIGURE 54. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 55. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2021 VS 2027 (%)
FIGURE 56. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2021 VS 2027 (USD MILLION)
FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2027
FIGURE 58. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2019-2027 (USD MILLION)
FIGURE 59. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 60. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, 2019-2027 (USD MILLION)
FIGURE 61. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 62. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, 2019-2027 (USD MILLION)
FIGURE 63. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 64. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2019-2027 (USD MILLION)
FIGURE 65. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 66. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, 2019-2027 (USD MILLION)
FIGURE 67. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 68. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, 2019-2027 (USD MILLION)
FIGURE 69. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 70. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, 2019-2027 (USD MILLION)
FIGURE 71. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 72. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 73. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 74. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2027
FIGURE 75. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2019-2027 (USD MILLION)
FIGURE 76. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 77. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2019-2027 (USD MILLION)
FIGURE 78. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 79. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, 2019-2027 (USD MILLION)
FIGURE 80. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 81. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, 2019-2027 (USD MILLION)
FIGURE 82. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 83. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, 2019-2027 (USD MILLION)
FIGURE 84. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 85. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2019-2027 (USD MILLION)
FIGURE 86. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 87. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2019-2027 (USD MILLION)
FIGURE 88. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 89. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, 2019-2027 (USD MILLION)
FIGURE 90. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 91. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2019-2027 (USD MILLION)
FIGURE 92. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 93. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, 2019-2027 (USD MILLION)
FIGURE 94. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 95. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2019-2027 (USD MILLION)
FIGURE 96. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 97. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, 2019-2027 (USD MILLION)
FIGURE 98. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 99. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, 2019-2027 (USD MILLION)
FIGURE 100. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 101. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, 2019-2027 (USD MILLION)
FIGURE 102. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 103. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, 2019-2027 (USD MILLION)
FIGURE 104. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 105. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 106. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 107. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 108. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2027
FIGURE 109. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 110. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 111. CANADA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 112. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 113. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 114. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 115. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 116. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2027
FIGURE 117. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 118. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 119. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 120. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2027
FIGURE 121. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 122. CHINA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 123. INDIA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 124. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 125. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 126. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 127. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 128. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 129. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 130. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 131. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 132. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 133. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 134. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 135. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2027
FIGURE 136. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 137. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 138. ITALY RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 139. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 140. QATAR RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 141. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 142. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 143. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 144. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 145. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 146. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 147. GLOBAL RADIOPHARMACEUTICALS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 148. GLOBAL RADIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 149. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RADIOPHARMACEUTICALS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL RADIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY REGION, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY STATE, 2019-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 54. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 59. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 64. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY REGION, 2019-2027 (USD MILLION)
TABLE 67. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY STATE, 2019-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY REGION, 2019-2027 (USD MILLION)
TABLE 72. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY STATE, 2019-2027 (USD MILLION)
TABLE 74. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY REGION, 2019-2027 (USD MILLION)
TABLE 77. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY STATE, 2019-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY REGION, 2019-2027 (USD MILLION)
TABLE 82. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY STATE, 2019-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY REGION, 2019-2027 (USD MILLION)
TABLE 87. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY STATE, 2019-2027 (USD MILLION)
TABLE 89. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 91. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2019-2027 (USD MILLION)
TABLE 92. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY STATE, 2019-2027 (USD MILLION)
TABLE 94. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 96. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY REGION, 2019-2027 (USD MILLION)
TABLE 97. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 98. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY STATE, 2019-2027 (USD MILLION)
TABLE 99. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 101. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY REGION, 2019-2027 (USD MILLION)
TABLE 102. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 103. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY STATE, 2019-2027 (USD MILLION)
TABLE 104. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 106. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY REGION, 2019-2027 (USD MILLION)
TABLE 107. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 108. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY STATE, 2019-2027 (USD MILLION)
TABLE 109. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 111. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY REGION, 2019-2027 (USD MILLION)
TABLE 112. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 113. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY STATE, 2019-2027 (USD MILLION)
TABLE 114. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 116. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 117. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2019-2027 (USD MILLION)
TABLE 118. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 119. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY STATE, 2019-2027 (USD MILLION)
TABLE 120. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 122. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY REGION, 2019-2027 (USD MILLION)
TABLE 123. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 124. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY STATE, 2019-2027 (USD MILLION)
TABLE 125. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 127. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY REGION, 2019-2027 (USD MILLION)
TABLE 128. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 129. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY STATE, 2019-2027 (USD MILLION)
TABLE 130. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 132. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2019-2027 (USD MILLION)
TABLE 133. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 134. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY STATE, 2019-2027 (USD MILLION)
TABLE 135. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 137. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY REGION, 2019-2027 (USD MILLION)
TABLE 138. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 139. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY STATE, 2019-2027 (USD MILLION)
TABLE 140. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 142. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY REGION, 2019-2027 (USD MILLION)
TABLE 143. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 144. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY STATE, 2019-2027 (USD MILLION)
TABLE 145. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 147. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY REGION, 2019-2027 (USD MILLION)
TABLE 148. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 149. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY STATE, 2019-2027 (USD MILLION)
TABLE 150. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 152. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 153. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 154. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 155. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 156. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 158. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 159. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 160. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 161. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 163. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 164. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 165. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 166. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 168. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 169. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 170. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 171. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 173. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 174. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 175. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 176. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 178. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 179. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 180. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 181. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 183. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 184. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 185. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 186. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 188. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2019-2027 (USD MILLION)
TABLE 189. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 190. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY STATE, 2019-2027 (USD MILLION)
TABLE 191. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 193. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 194. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 195. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 196. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 198. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY REGION, 2019-2027 (USD MILLION)
TABLE 199. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 200. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY STATE, 2019-2027 (USD MILLION)
TABLE 201. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 203. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 204. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 205. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 206. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 208. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 209. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 210. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 211. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 213. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 214. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 215. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 216. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 218. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY REGION, 2019-2027 (USD MILLION)
TABLE 219. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 220. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY STATE, 2019-2027 (USD MILLION)
TABLE 221. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 223. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY REGION, 2019-2027 (USD MILLION)
TABLE 224. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 225. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY STATE, 2019-2027 (USD MILLION)
TABLE 226. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 228. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 229. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 230. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 231. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 232. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 233. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 234. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 235. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 236. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 237. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 238. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 239. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 240. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 241. CANADA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 242. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 243. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 244. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 245. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 246. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 247. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 248. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 249. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 250. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 251. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 252. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 253. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 254. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 255. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 256. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 257. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 258. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 259. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 260. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 261. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 262. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 263. CHINA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 264. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 265. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 266. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 267. INDIA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 268. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 269. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 270. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 271. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 272. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 273. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 274. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 275. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 276. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 277. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 278. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 279. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 280. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 281. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 282. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 283. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 284. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 285. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 286. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 287. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 288. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 289. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 290. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 291. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 292. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 293. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 294. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 295. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 296. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 297. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 298. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 299. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 300. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 301. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019-2027 (USD MILLION)
TABLE 302. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA RADIOPH

Companies Mentioned

  • Alliance Holdings Medical Limited
  • Bayer AG
  • Beijing International Pharmaceutical Technology Co., Ltd.
  • Bracco Group
  • Cardinal Health, Inc.
  • Clarity Pharmaceuticals
  • Curium Pharma
  • Eckert & Ziegler Group
  • Eczacibasi-Monrol Nuclear Products Co.
  • Fusion Pharmaceuticals Inc.
  • GE Healthcare
  • Global Medical Solutions, LTD.
  • Institute of Isotopes Co., LTD.
  • IsoTherapeutics Group, LLC
  • Isotopia Molecular Imaging Ltd.
  • Jubilant Pharma Holdings Inc.
  • Lantheus Medical Imaging, Inc.
  • Mallinckrodt PLC
  • Navidea Biopharmaceuticals, Inc.
  • Northstar Medical Technologies LLC
  • Novartis AG
  • NTP Radioisotopes SOC Ltd.
  • PharmaLogic Holdings LLC
  • SHINE Medical Technologies
  • Siemens Healthineers AG
  • Sotera Health Holdings, LLC
  • State Atomic Energy Corporation Rosatom

Methodology

Loading
LOADING...